Global Infertility
Devices Market, by Product Type (Equipment and Accessories), by Procedure
(Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery,
and Others), by Gender (Male and Female), by End User (Fertility Centers,
Hospitals & Surgical Clinics, Cryobanks, and Others), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at
US$ 7,104.1 million in 2018, and is
expected to exhibit a CAGR of 8.4% over the forecast period (2019-2027).
Increasing adoption of
collaborations and partnerships by key players are expected to propel the
market growth over the forecast period. For instance, in October 2019, Carl
Zeiss Meditec AG entered into a partnership with Kyoto University to increase
the company’s research and development capabilities. Similarly, in November
2019, Invo Bioscience announced that they have entered commercialization
agreements for the InvoCell in-vivo fertility system in Turkey and Jordan, to
support the company’s expansion into Middle East.
Rising prevalence of infertility
is expected to boost growth of the infertility devices market over the forecast
period. For instance, according to the International Journal of Women’s Health
and Reproduction Sciences, in 2018, the global prevalence of infertility was
10-15%. According to the same data source, in Iran, couples suffering from
primary and secondary fertility problems were around 78.4% and 21.6%,
respectively in 2018.
Moreover, increasing government
funding programs for infertility is further expected to drive the infertility
devices market growth over the forecast period. For instance, in December 2015,
Ontario (Canada) government launched the Ontario Fertility Program to provide
funds to help infertile patients to overcome such infertility problems.
Moreover, access to funded fertility services was available for all forms of
infertility (including medical and non-medical infertility), regardless of
gender, sexual orientation, or family status.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2579
Browse 38 Market Data Tables and
29 Figures spread through 214 Pages and in-depth TOC on ‘Infertility Devices
Market’- Global Forecast to 2027, by Product Type (Equipment and Accessories),
by Procedure (Assisted Reproductive Technology, Artificial Insemination,
Fertility Surgery, and Others), by Gender (Male and Female), by End User
(Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, and Others),
and by Region (North America, Latin America, Europe, Asia Pacific, Middle East,
and Africa)
expected to hold a dominant
position in the infertility devices market over the forecast period, owing to
adoption of growth strategies such as product launches, investments, and
facility expansion by the market players in the region to enhance their market
presence. For instance, in November 2015, INVO Bioscience, Inc., a medical
device company announced that the U.S. Food and Drug Administration (FDA)
approved company's De Novo request for INVOcell. INVOcell is the first intravaginal culture
system that was granted marketing clearance in the U.S.
Moreover, rising adoption of
inorganic growth strategies such as distribution agreement, collaborations, and
acquisitions by market players in North America are expected to boost the
infertility devices market growth in the region during the forecast period. For
instance, in November 2018, Ferring Pharmaceuticals signed an agreement to
acquire the exclusive U.S. commercialization rights for the INVOcell
intravaginal culture (IVC) system from INVO Bioscience Inc. The system includes
the INVOcell IVC device, retention device, and holding block.
Furthermore, Europe is expected
to witness significant growth in the infertility devices market during the
forecast period, owing to favorable reimbursement policies by governments for
infertility treatment. For instance, according to the European Policy Audit on
Fertility (EPAF) rules, there is 100% coverage for women under 43 years for
four IVF treatments and up to six IUI treatments in France.
Key Takeaways of the Infertility
Devices Market:
The global infertility devices market
is expected to exhibit a CAGR of 8.4% over the forecast period, owing to
increasing adoption of collaborations and acquisition strategies by the market
players, and rising products approvals by regulatory organizations. For
instance, in October 2019, INVO Bioscience, Inc., a medical device company
focused on creating alternative treatments for patients diagnosed with
infertility, announced about receiving the CE mark for its INVOcell culture and
retention device.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/infertility-devices-market-2579
Among product type, equipment
segment held dominant position in the infertility devices market in 2018, owing
to increasing research and innovation in the field of fertility by the research
institutes. For instance, in 2018, researcher at Worcester Polytechnic
Institute developed a device named Spartan. The Spartan device helps women to
get pregnant with fewer treatment trials in IVF fertilization by selecting
faster and healthier sperm. The Spartan name is the short form of Simple
Periodic Array for Trapping and Isolation. This device uses field of
three-dimensional posts to create obstacle of array through which sperm passes
to outlet. The fastest and healthiest sperm that gets into the outlet are used
for further IVF (In vitro fertilization) procedure.
Among procedure, Assisted
Reproductive Technology (ART) procedure segment held dominant position in the
infertility devices market in 2018, owing to increasing innovation and
development in ART. For instance, in 2017, Esco Medical Group launched
Semi-Closed Environment (SCE) IVF device to provide controlled environment,
while handling the gamete and embryo in IVF procedure.
Among gender, females segment
held dominant position in the infertility devices market in 2018, owing to
rising prevalence of infertility. For instance, according to the data by
National Survey of Family Growth (NSFG) published in 2018 indicates that in the
U.S., around 5.5% of all female population were infertile and 6.7% of married
women aged 15 to 44 years were infertile.
Companies operating in the global
infertility devices market include Carl Zeiss Meditec AG, Thermo Fisher
Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies,
Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn
Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook
Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech
Pvt. LTD
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2579
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment